STOCKSCREENR
Log In

RVTY

NYSE

Revvity, Inc.

$87.37+0.89(+1.03%)Mkt Cap: $9.91B

Key Stats

Market Cap

$9.91B

P/E Ratio

42.41

EPS

$2.06

Dividend Yield

0.31%

52-Week Range

$81.36 — $118.30

Volume

728.27K

Avg Volume

1.34M

Beta

1.11

Valuation

P/E (TTM)

42.41

Forward P/E

16.18

PEG Ratio

9.46

P/S (TTM)

3.63

P/B (TTM)

1.43

P/FCF

67.95

EV/EBITDA

140.01x

EV/Sales

—

Financial Health

ROE (TTM)

0.03%

ROA (TTM)

0.02%

ROIC

0.01%

Gross Margin

0.50%

Operating Margin

0.13%

Net Margin

0.13%

Debt/Equity

0.48

Current Ratio

1.68

Growth

EPS Growth (YoY)

+0.11%

Revenue Growth (YoY)

+0.14%

EPS Growth (3Y)

+0.73%

EPS Growth (5Y)

+0.40%

Sales Growth (3Y)

-0.04%

Sales Growth (5Y)

-0.05%

EPS Est (This Year)

$5.40

EPS Est (Next Year)

$5.98

Dividends

Dividend Yield

—

Annual Dividend

$0.07

Payout Ratio

0.08%

Frequency

—

Ex-Dividend Date

2025-10-17

Cash/Share

$8.12

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$105.00$118.00$129.00
LowMedianHigh

Consensus Target: $115.14(31.8% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

116.07M

Float

103.98M

Free Float %

89.58%

Technicals

RSI (14)

39.90

SMA 20

$109.54

SMA 50

$103.93

SMA 200

$95.81

ATR (14)

4.20

Volatility (Week)

0.04%

Volatility (Month)

0.03%

Pattern

—

Performance

1 Day

+1.88%

1 Week

+3.58%

1 Month

+0.31%

3 Months

+15.39%

6 Months

+22.09%

1 Year

—

YTD

+6.72%

All-Time High

$120.39

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

NYSE

IPO Date

1965-07-06

Employees

11000

CEO

Prahlad R. Singh

Index Membership

S&P 500

Website

https://www.perkinelmer.com

Revvity, Inc. (RVTY) is a healthcare company in the medical - diagnostics & research industry listed on the NYSE. With a market capitalization of $9.91B, a P/E ratio of 42.41, and a dividend yield of 0.31%, RVTY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RVTY against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0KHE.L

Revvity, Inc.

$88.87

+3.35%

$9.89B

LH

Labcorp Holdings Inc.

$270.62

+1.41%

$22.43B

ILMN

Illumina, Inc.

$120.84

+1.31%

$18.48B

NTRA

Natera, Inc.

$198.38

+0.35%

$28.12B

MEDP

Medpace Holdings, Inc.

$455.15

+0.33%

$12.92B

RDNT

RadNet, Inc.

$63.63

-0.73%

$4.94B

Frequently Asked Questions

What is Revvity, Inc.'s P/E ratio?

Revvity, Inc. (RVTY) has a trailing twelve-month (TTM) P/E ratio of 42.41. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Revvity, Inc. pay a dividend?

No, Revvity, Inc. (RVTY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Revvity, Inc.'s market cap?

Revvity, Inc. (RVTY) has a market capitalization of $9.91 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about RVTY?

Wall Street analysts have a consensus "Buy" rating on Revvity, Inc. (RVTY) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $115.14 implies 31.8% upside from the current price.

How has RVTY performed this year?

Revvity, Inc. (RVTY) has returned +6.72% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.